Skip to content

Clinical trials

Observational Lung Diseases, Interstitial trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Phase: Observational Country / region: Canada Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20191
20211
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Laval University1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
University of Alberta1
University of California, San Francisco1
University of Massachusetts, Worcester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial6
Dyspnea2
Connective Tissue Diseases1
Disease Progression1
Idiopathic Pulmonary Fibrosis1
Lupus Erythematosus, Systemic1
Mobility Limitation1
Pulmonary Disease, Chronic Obstructive1
Pulmonary Fibrosis1
Rheumatic Diseases1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.